Laminin β4 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoid
Stephanie Goletz,Manuela Pigors,Tina Rastegar Lari,Christoph M Hammers,Yao Wang,Shirin Emtenani,Monique Aumailley,Maike M Holtsche,Felix H Stang,Imke Weyers,Inke R König,Cristina Has,Christiane Radzimski,Lars Komorowski,Detlef Zillikens,Enno Schmidt,Christoph M. Hammers,Maike M. Holtsche,Felix H. Stang,Inke R. König
DOI: https://doi.org/10.1016/j.jaad.2023.11.014
IF: 15.487
2023-11-22
Journal of the American Academy of Dermatology
Abstract:Background Anti-p200 pemphigoid is a subepidermal autoimmune blistering disease (AIBD) characterized by autoantibodies against a 200 kDa protein. Laminin γ1 has been described as target antigen in 70-90% of patients. No diagnostic assay is widely available for anti-p200 pemphigoid, which might be due to the unclear pathogenic relevance of anti-laminin γ1 autoantibodies. Objective To identify a target antigen with higher clinical and diagnostic relevance. Methods Immunoprecipitation, mass spectrometry, and immunoblotting were employed for analysis of skin extracts and sera of patients with anti-p200 pemphigoid (n=60), other AIBD (n=33), and healthy blood donors (n=29). To localize the new antigen in skin, cultured keratinocytes and fibroblasts, quantitative real-time PCR and immunofluorescence microscopy were performed. Results Laminin β4 was identified as target antigen of anti-p200 pemphigoid in all analyzed patients. It was located at the level of the basement membrane zone of the skin with predominant expression in keratinocytes. Limitations A higher number of sera needs to be tested to verify that laminin β4 is the diagnostically relevant antigen of anti-p200 pemphigoid. Conclusion The identification of laminin β4 as an additional target antigen in anti-p200 pemphigoid will allow its differentiation from other AIBD and as such, improve the management of these rare disorders.
dermatology